A citation-based method for searching scientific literature

James G Nicholson, Howard A Fine. Cancer Discov 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evolutionary dynamics of residual disease in human glioblastoma.
I Spiteri, G Caravagna, G D Cresswell, A Vatsiou, D Nichol, A Acar, L Ermini, K Chkhaidze, B Werner, R Mair,[...]. Ann Oncol 2019
21
50

Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system.
Emilie Le Rhun, Joan Seoane, Michel Salzet, Riccardo Soffietti, Michael Weller. Cancer Lett 2020
13
50

Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA.
Changcun Pan, Bill H Diplas, Xin Chen, Yuliang Wu, Xiong Xiao, Liping Jiang, Yibo Geng, Cheng Xu, Yu Sun, Peng Zhang,[...]. Acta Neuropathol 2019
41
50


Spatiotemporal genomic architecture informs precision oncology in glioblastoma.
Jin-Ku Lee, Jiguang Wang, Jason K Sa, Erik Ladewig, Hae-Ock Lee, In-Hee Lee, Hyun Ju Kang, Daniel S Rosenbloom, Pablo G Camara, Zhaoqi Liu,[...]. Nat Genet 2017
116
50

Mechanisms and therapeutic implications of hypermutation in gliomas.
Mehdi Touat, Yvonne Y Li, Adam N Boynton, Liam F Spurr, J Bryan Iorgulescu, Craig L Bohrson, Isidro Cortes-Ciriano, Cristina Birzu, Jack E Geduldig, Kristine Pelton,[...]. Nature 2020
101
50

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.
Brett E Johnson, Tali Mazor, Chibo Hong, Michael Barnes, Koki Aihara, Cory Y McLean, Shaun D Fouse, Shogo Yamamoto, Hiroki Ueda, Kenji Tatsuno,[...]. Science 2014
761
50

Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas.
Yasukazu Fukuya, Soko Ikuta, Takashi Maruyama, Masayuki Nitta, Taiichi Saito, Shunsuke Tsuzuki, Mikhail Chernov, Takakazu Kawamata, Yoshihiro Muragaki. J Neurooncol 2019
10
50

Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.
Alexandra M Miller, Ronak H Shah, Elena I Pentsova, Maryam Pourmaleki, Samuel Briggs, Natalie Distefano, Youyun Zheng, Anna Skakodub, Smrutiben A Mehta, Carl Campos,[...]. Nature 2019
149
50

Longitudinal molecular trajectories of diffuse glioma in adults.
Floris P Barthel, Kevin C Johnson, Frederick S Varn, Anzhela D Moskalik, Georgette Tanner, Emre Kocakavuk, Kevin J Anderson, Olajide Abiola, Kenneth Aldape, Kristin D Alfaro,[...]. Nature 2019
99
50

Mutations and mechanisms of WNT pathway tumour suppressors in cancer.
Jeroen M Bugter, Nicola Fenderico, Madelon M Maurice. Nat Rev Cancer 2021
20
50

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer.
Alessandro Leal, Nicole C T van Grieken, Doreen N Palsgrove, Jillian Phallen, Jamie E Medina, Carolyn Hruban, Mark A M Broeckaert, Valsamo Anagnostou, Vilmos Adleff, Daniel C Bruhm,[...]. Nat Commun 2020
32
50

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
Yu-Hsiang Chen, Bradley A Hancock, Jeffrey P Solzak, Dumitru Brinza, Charles Scafe, Kathy D Miller, Milan Radovich. NPJ Breast Cancer 2017
45
50

Liquid biopsy and minimal residual disease - latest advances and implications for cure.
Klaus Pantel, Catherine Alix-Panabières. Nat Rev Clin Oncol 2019
242
50

Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.
Tej D Azad, Aadel A Chaudhuri, Penny Fang, Yawei Qiao, Mohammad S Esfahani, Jacob J Chabon, Emily G Hamilton, Yi D Yang, Alex Lovejoy, Aaron M Newman,[...]. Gastroenterology 2020
33
50

Management of glioblastoma: State of the art and future directions.
Aaron C Tan, David M Ashley, Giselle Y López, Michael Malinzak, Henry S Friedman, Mustafa Khasraw. CA Cancer J Clin 2020
78
50

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
50

The Role of Liquid Biopsies in Detecting Molecular Tumor Biomarkers in Brain Cancer Patients.
Heena Sareen, Celine Garrett, David Lynch, Branka Powter, Daniel Brungs, Adam Cooper, Joseph Po, Eng-Siew Koh, Joey Yusof Vessey, Simon McKechnie,[...]. Cancers (Basel) 2020
8
50


The multiple mechanisms that regulate p53 activity and cell fate.
Antonina Hafner, Martha L Bulyk, Ashwini Jambhekar, Galit Lahav. Nat Rev Mol Cell Biol 2019
240
50

Regulating tumor suppressor genes: post-translational modifications.
Ling Chen, Shuang Liu, Yongguang Tao. Signal Transduct Target Ther 2020
22
50

Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis.
Verena Körber, Jing Yang, Pankaj Barah, Yonghe Wu, Damian Stichel, Zuguang Gu, Michael Nai Chung Fletcher, David Jones, Bettina Hentschel, Katrin Lamszus,[...]. Cancer Cell 2019
59
50

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
Jann N Sarkaria, Leland S Hu, Ian F Parney, Deanna H Pafundi, Debra H Brinkmann, Nadia N Laack, Caterina Giannini, Terence C Burns, Sani H Kizilbash, Janice K Laramy,[...]. Neuro Oncol 2018
157
50

Characterization of basigin isoforms and the inhibitory function of basigin-3 in human hepatocellular carcinoma proliferation and invasion.
Cheng-Gong Liao, Ling-Min Kong, Fei Song, Jin-Liang Xing, Long-Xin Wang, Zhi-Jian Sun, Hao Tang, Hui Yao, Yang Zhang, Li Wang,[...]. Mol Cell Biol 2011
49
50

Cancer stem cells in glioblastoma.
Justin D Lathia, Stephen C Mack, Erin E Mulkearns-Hubert, Claudia L L Valentim, Jeremy N Rich. Genes Dev 2015
674
50

Stem cells, cancer, and cancer stem cells.
T Reya, S J Morrison, M F Clarke, I L Weissman. Nature 2001
50

NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma.
Tobias Weiss, Michael Weller, Matthias Guckenberger, Charles L Sentman, Patrick Roth. Cancer Res 2018
84
50


A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.
Fadi Jacob, Ryan D Salinas, Daniel Y Zhang, Phuong T T Nguyen, Jordan G Schnoll, Samuel Zheng Hao Wong, Radhika Thokala, Saad Sheikh, Deeksha Saxena, Stefan Prokop,[...]. Cell 2020
142
50

Use of chlorotoxin for targeting of primary brain tumors.
L Soroceanu, Y Gillespie, M B Khazaeli, H Sontheimer. Cancer Res 1998
162
50

Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells.
Juliane Gust, Kevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, David Myerson, Luis F Gonzalez-Cuyar, Cecilia Yeung, W Conrad Liles, Mark Wurfel, Jose A Lopez,[...]. Cancer Discov 2017
479
50

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim, Charles S Cobbs, Jason A Heth, Michael Salacz, Sarah Taylor, Stacy D D'Andre,[...]. J Transl Med 2018
149
50


FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance.
Sara Caratelli, Tommaso Sconocchia, Roberto Arriga, Andrea Coppola, Giulia Lanzilli, Davide Lauro, Adriano Venditti, Maria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo,[...]. Front Immunol 2017
21
50


CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA.
Federica Riccardo, Selina Iussich, Lorella Maniscalco, Saray Lorda Mayayo, Giuseppe La Rosa, Maddalena Arigoni, Raffaella De Maria, Francesca Gattino, Stefania Lanzardo, Elena Lardone,[...]. Clin Cancer Res 2014
37
50


Expression of hypoxia-inducible carbonic anhydrases in brain tumors.
Martin A Proescholdt, Christina Mayer, Marion Kubitza, Thomas Schubert, Shu-Yuan Liao, Eric J Stanbridge, Sergey Ivanov, Edward H Oldfield, Alexander Brawanski, Marsha J Merrill. Neuro Oncol 2005
63
50

Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.
Bryan D Choi, Marcela V Maus, Carl H June, John H Sampson. Clin Cancer Res 2019
25
50

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia.
David L Porter, Wei-Ting Hwang, Noelle V Frey, Simon F Lacey, Pamela A Shaw, Alison W Loren, Adam Bagg, Katherine T Marcucci, Angela Shen, Vanessa Gonzalez,[...]. Sci Transl Med 2015
900
50

Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.
Xuekai Zhu, Shruthi Prasad, Simone Gaedicke, Michael Hettich, Elke Firat, Gabriele Niedermann. Oncotarget 2015
67
50

EGFRvIII: An Oncogene with Ambiguous Role.
Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Karolina Janik, Aneta Włodarczyk, Piotr Rieske. J Oncol 2019
10
50


CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors.
Robbie G Majzner, Johanna L Theruvath, Anandani Nellan, Sabine Heitzeneder, Yongzhi Cui, Christopher W Mount, Skyler P Rietberg, Miles H Linde, Peng Xu, Christopher Rota,[...]. Clin Cancer Res 2019
128
50

The B7 family of immune-regulatory ligands.
Mary Collins, Vincent Ling, Beatriz M Carreno. Genome Biol 2005
171
50

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
Quinn T Ostrom, Gino Cioffi, Haley Gittleman, Nirav Patil, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2019
563
50

Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy.
Serena Pellegatta, Barbara Savoldo, Natalia Di Ianni, Cristina Corbetta, Yuhui Chen, Monica Patané, Chuang Sun, Bianca Pollo, Soldano Ferrone, Francesco DiMeco,[...]. Sci Transl Med 2018
57
50

Regulation of antiviral T cell responses by type I interferons.
Josh Crouse, Ulrich Kalinke, Annette Oxenius. Nat Rev Immunol 2015
209
50

Type I interferon is selectively required by dendritic cells for immune rejection of tumors.
Mark S Diamond, Michelle Kinder, Hirokazu Matsushita, Mona Mashayekhi, Gavin P Dunn, Jessica M Archambault, Hsiaoju Lee, Cora D Arthur, J Michael White, Ulrich Kalinke,[...]. J Exp Med 2011
567
50

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma.
Kurt A Schalper, Maria E Rodriguez-Ruiz, Ricardo Diez-Valle, Alvaro López-Janeiro, Angelo Porciuncula, Miguel A Idoate, Susana Inogés, Carlos de Andrea, Ascensión López-Diaz de Cerio, Sonia Tejada,[...]. Nat Med 2019
192
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.